AXIS Capital Holdings Limited’s (AXS) shares have rallied 58.5% in the past year compared with the industry's growth of 23.9%. The Finance sector and the Zacks S&P 500 index have returned 21.2% and 26.7%, respectively, in the said time frame. With a market capitalization of $7.43 billion, the average volume of shares traded in the last three months was 0.5 million. Currently priced at $88.87, the stock is slightly below its 52-week high of $94.89.AXS Outperforms Industry, Sector, S&P in a YearImage Source: ...

The Zacks Property and Casualty Insurance industry has performed well so far this year, riding on better pricing, prudent underwriting standards, increased exposure, streamlined operations, a wider global presence and a solid capital position. Increased technology advancements and an improving rate environment have added to the upside. However, geopolitical tensions, particularly conflicts in the Middle East and Ukraine, high inflation and catastrophe events, both natural and man-made put pressure on non-li ...

Global speciality underwriter and insurance and reinsurance solutions provider, AXIS Capital Holdings Limited (NYSE: AXS ) has succeeded thanks to its ability to price complex risks and achieve high levels of profitability. Despite compounding core profits by more than 30% aAn economics graduate with a passion for financial history; I apply my knowledge to markets in an effort to hopelessly predict trends and spot value. All opinions are my own and should not be taken seriously.Analyst’s Disclosure: I/we ha ...

PEMBROKE, Bermuda, Dec. 16, 2024 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or "the Company") (NYSE:AXS) and Enstar Group Limited ("Enstar") (NASDAQ:ESGR) today announced that they have entered into a loss portfolio transfer ("LPT") reinsurance agreement covering a portfolio of reinsurance segment business. The closing of the transaction is subject to regulatory approvals and other customary conditions, and is expected to occur during the first half of 2025. Under the LPT re ...

The price-to-book (P/B) ratio is widely favored by value investors for identifying low-priced stocks with exceptional returns. The ratio is used to compare a stock’s market value/price to its book value.The P/B ratio is calculated as below:P/B ratio = market price per share/book value of equity per shareThe P/B ratio reflects how many times book value investors are ready to pay for a share. So, if the share price is $10 and the book value of equity is $5, investors are ready to pay two times the book value. ...

Key TakeawaysTyson Foods, AXIS Capital, Pfizer and General Motors stocks boast a low price to cash flow ratio (P/CF).P/CF ratio evaluates the market price of a stock relative to the amount of cash flow on a per-share basis.Register now to see our 7 Best Stocks for the Next 30 Days report - free today!The U.S. stock market retreated on Wednesday as investors booked profits and adopted a cautious approach after earlier gains in November. The pullback came as market participants evaluated fresh economic data a ...

It has been about a month since the last earnings report for Axis Capital (AXS) . Shares have added about 19.9% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Axis Capital due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. AXIS Capital Q3 Earnings and Revenues Beat, P ...

Earlier this week, Axsome (NASDAQ: AXSM ) published topline data from the open-label, follow on phase 3 study of AXS-12 (reboxetine) for the treatment of narcolepsy patients with cataplexy. The trial met its primary endpoint of change in frequency of weekly cataplexy attacks fromAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticke ...

On Tuesday, Axsome Therapeutics Inc AXSM said AXS-12 statistically significantly reduced the frequency of cataplexy attacks compared to placebo (p=0.017, primary endpoint) in Phase 3 ENCORE trial.AXS-12 was also well tolerated with long-term dosing, and its safety profile was consistent with that observed in previously completed trials.The primary endpoint was achieved with patients randomized to switch to placebo experiencing a mean increase of 10.29 cataplexy attacks per week compared to a mean increase o ...

Shares of AXIS Capital Holdings (AXS) have rallied 64.7% year to date, compared with the industry’s increase of 33.4%, the Finance sector’s rise of 23.2% and the Zacks S&P 500 composite’s rise of 25.3%. With a market capitalization of $7.6 billion, the average volume of shares traded in the last three months was 0.5 million.A compelling and diversified product portfolio, underwriting excellence, digital capabilities and solid capital position continue to drive this specialty and global reinsurer. AXS vs Ind ...